2019 Global Suppliers of Immunodiagnostic, Microbiology, Cancer Diagnostic, Molecular Diagnostic, Hematology, Coagulation and Blood Banking Analyzers and Reagents
This new report provides analyses of 100 major and emerging suppliers of immunodiagnostics, microbiology, cancer diagnostic, molecular diagnostic, hematology, coagulation and blood banking instruments and reagents. The report presents strategic profiles of 100 major and emerging suppliers of diagnostic products, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
Companies analyzed in the report include
- Abbott
- Accriva
- Affymetrix
- Agilent Technologies
- Alere/AdnaGen
- Applied Gene Technologies
- Arca Biopharma
- Axis-Shield
- Bayer Healthcare
- Beckman Coulter/Danaher
- Becton Dickinson
- Bio/Data
- Biokit
- Biomedical Diagnostics/Theradiag
- Biomerieux
- Bio-Rad
- Cellavision
- Cepheid
- Chrono-Log
- Corgenix Medical
- Decode Genetics
- Diadexus
- Diagast
- Diagnocure
- Diagnostica Stago
- Diamedix
- Diasorin
- Eiken Chemical
- EKF Diagnostics
- Elitech Group
- Enterix/Clinical Genomics
- Enzo Biochem
- Epigenomics
- Exact Sciences
- Fujirebio
- Gen-Probe/Hologic
- Grifols
- Guided Therapeutics
- Helena Laboratories
- Horiba
- Hyphen BioMed
- ID Biomedical/GSK
- Illumina
- Immucor
- Instrumentation Laboratory
- Iris Diagnostics/Danaher
- Kreatech/Leica
- Kyowa Medex
- LabCorp
- Li-Cor Biosciences
- Lonza
- Mackay Life Sciences
- Matritech/Alere
- Monogram Biosciences/LabCorp
- Myriad Genetics
- Nihon Kohden
- OncoLab
- Ortho-Clinical Diagnostics
- Panacea Pharmaceuticals
- Perkin Elmer/Caliper
- Polartechnics
- Polymedco
- PreMD
- Proteome Sciences
- Qiagen
- Quest Diagnostics
- Quidel
- Radiant Pharmaceuticals
- Roche
- Scienion
- SDIX
- Sekisui Diagnostics
-Sequenom
- SeraCare
- Shimadzu
- Siemens
- Sienco
- Sierra Molecular
- Sysmex
- Takara Bio
- Targeted Diagnostics & Therapeutics
- Tecan Group
- Thermo Fisher
- Tosoh
- Trinity Biotech
- Veridex
- Vermillion
- Wako
- Wallac/PE
- Zycare/Alere
- Zyla
SECTION I: EXECUTIVE SUMMARY
- A 3-5 page synopsis of key sections.
SECTION II: BUSINESS ORGANIZATION
- History of the companys paint and coatings business evolution, which is important to understanding
the corporate culture, management mentality and strategies.
- Recent acquisitions, divestitures and major organizational changes.
- Current organizational structure.
SECTION III: SENIOR MANAGEMENT
- Names, titles and background of key executives.
SECTION IV: FACILITIES AND EMPLOYEES
- Administrative, manufacturing and R&D facilities in the U.S. and abroad.
- Manufacturing practices.
- New plants under construction.
- The U.S. and international work force size and distribution.
SECTION V: TECHNOLOGICAL KNOW-HOW
- Internally developed and acquired paint and coatings and related capabilities.
- Proprietary technologies and patent litigation.
SECTION VI: PRODUCT PORTFOLIO
- Review of major product lines.
- Applications, advantages and weaknesses of leading products.
SECTION VII: MARKETING TACTICS
- Promotional tactics.
- Distribution approaches.
- Product service and support.
- Customer relations.
SECTION VIII: FINANCIAL ANALYSIS
- Estimated sales by division, geographic region and product line. .
- Five-year sales and operating profit performance.
SECTION IX: R&D EXPENDITURES AND MAJOR PROGRAMS
- Estimated R&D budget.
- Research facilities and staff.
- New technologies, products and applications in development.
SECTION X: COLLABORATIVE ARRANGEMENTS
- Joint ventures, distribution, O.E.M. and licensing partners, both industrial and academic.
- Terms of collaborative agreements and specific products involved.
SECTION XI: STRATEGIC DIRECTION
- Specific business, new product development and marketing strategies.
- Strengths and weaknesses, e.g., managerial, organizational, marketing and product development.
- Anticipated acquisitions, joint ventures and divestitures.
2020 Global Nucleic Acid Testing/NAT Market, 2019-2023: Emerging Opportunities in US, Europe, Japan--Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts--Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing
This new seven-country study contains 1,398 pages, 194 tables, and is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the molecular
USD 24500 View Report2024 Global Nucleic Acid Testing/NAT Market, 2019-2023: Emerging Opportunities in US, Europe, Japan--Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts--Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing
This new seven-country study contains 1,398 pages, 194 tables, and is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the molecular
USD 24500 View ReportGlobal Suppliers of Immunodiagnostic, Microbiology, Cancer Diagnostic, Molecular Diagnostic, Hematology, Coagulation and Blood Banking Analyzers and Reagents
This new report provides analyses of 100 major and emerging suppliers of immunodiagnostics, microbiology, cancer diagnostic, molecular diagnostic, hematology, coagulation and blood banking instruments and reagents. The report presents strategic
USD 4750 View Report2019 Global Thrombin Time Market: US, Europe, Japan--Volume and Sales Segmentation Forecasts, Competitive Landscape, Current Methods and Instrumentation, Opportunities for Suppliers
The growing cost-containment pressures in major industrialized nations and continued technological advances will radically change coagulation testing practice during the next five years. New specific and sensitive markers of
USD 3450 View ReportFill The Form For Sample Request